Datu Oto, Abuhair A.

HRN: 28-80-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/06/2026
04/12/2026
IV
250mg
Q6h
Pcap B
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: